A narrative review of proteolytic targeting chimeras (PROTACs): future perspective for prostate cancer therapy

Proteolysis-TArgeting Chimeras (PROTACs) technology, as a strategy to chemically knock down transcription factors at the protein levels, can hijack the ubiquitin-proteasome degradation system to initiate the intracellular ubiquitin-proteasome hydrolysis process to degrade proteins. In the past, the...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Transl Androl Urol
Hoofdauteurs: Chen, Xuanrong, Shen, Haishan, Shao, Yi, Ma, Qianwang, Niu, Yuanjie, Shang, Zhiqun
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AME Publishing Company 2021
Onderwerpen:
Review Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947434/
https://ncbi.nlm.nih.gov/pubmed/33718095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau-20-1357
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items